Relay Therapeutics (RLAY) EBT Margin (2020 - 2025)
Historic EBT Margin for Relay Therapeutics (RLAY) over the last 6 years, with Q2 2025 value amounting to 10301.62%.
- Relay Therapeutics' EBT Margin changed N/A to 10301.62% in Q2 2025 from the same period last year, while for Sep 2025 it was 3551.78%, marking a year-over-year decrease of 1017200.0%. This contributed to the annual value of 3374.86% for FY2024, which is 20362700.0% down from last year.
- Per Relay Therapeutics' latest filing, its EBT Margin stood at 10301.62% for Q2 2025.
- In the past 5 years, Relay Therapeutics' EBT Margin registered a high of 8349600.0% during Q4 2023, and its lowest value of 82765.55% during Q2 2023.
- In the last 5 years, Relay Therapeutics' EBT Margin had a median value of 11897.0% in 2021 and averaged 538492.43%.
- Per our database at Business Quant, Relay Therapeutics' EBT Margin plummeted by 2000000000bps in 2021 and then surged by 2000000000bps in 2023.
- Over the past 5 years, Relay Therapeutics' EBT Margin (Quarter) stood at 11897.0% in 2021, then tumbled by -124bps to 26671.54% in 2022, then soared by 31405bps to 8349600.0% in 2023, then crashed by -100bps to 813.55% in 2024, then tumbled by -1166bps to 10301.62% in 2025.
- Its last three reported values are 10301.62% in Q2 2025, 1003.46% for Q1 2025, and 813.55% during Q1 2024.